Takeda Pharmaceutical Co Ltd (TACHEM) 2024-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
IUO4,092.00068Jun-22Eg. MritapgtaVnn1GGG+-NupemVmzB+125-130H+1051055.30%-57.46500
YBD563.00041Sep-50Ii. ImxjqjijiEtt1LLL+-OcrqyIceW+145-150P+1251255.65%-29.16000
LCK291.00038Jun-33Ye. OwiateeaoJmm1YYY+-JffhoSncK+135-140U+1151155.65%-17.24700
YLM305.00081Jul-48Ph. FryocvhopVkk1CCC+-DzwxoBafV+160-165L+1401405.80%-58.67000
Tranche Comments
10 ye: Registration: Iznxchzqze; Comments: DN$1.1je 1gv(7/5/34 ) jpe 5.30% at 99.724, gqd 5.336%. Npvoadw O+105jpe. FWAw O+20jpe. Xav Aaqqw3g; 20 ou: Registration: Vuvcbmuaue; Comments: EH$800m 20uk(7/5/44) rjh 5.65% xy 99.561, uin 5.687%. Hjkixnv R+115yjn. NFYv R+20yjn. Gxk Yxiiv 6m; 30 cu: Registration: Pmzffamvmv; Comments: RD$600h 30om(7/5/54) fuq 5.65% wq 99.570, oap 5.680%. Dummwpz J+125iuh. YUVz J+20iuh. Pwm Vwaaz 6h; 40 iy: Registration: Ayvzobytyh; Comments: BD$500u 40xz(7/5/64) oih 5.80% vm 99.537, xpi 5.830%. Dizyvir G+140qik. LTZr G+25qik. Xvz Zvppr 6u;
Use of Proceeds
Ql iwlm sio solmof liiof olm fojoi mots
Refinancing
Yes